What is the recommended dose of local anesthetic for a supratrochlear supraorbital nerve block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Local Anesthetic for Supratrochlear Supraorbital Nerve Block

For a supratrochlear supraorbital nerve block, the recommended dose is 0.15 ml/kg of 0.25% bupivacaine, 0.25% levobupivacaine, or 0.2% ropivacaine. 1

Local Anesthetic Options and Dosing

  • For supratrochlear supraorbital nerve block, use one of the following long-acting local anesthetics 1:

    • Bupivacaine 0.25%: 0.15 ml/kg
    • Levobupivacaine 0.25%: 0.15 ml/kg
    • Ropivacaine 0.2%: 0.15 ml/kg
  • Maximum safe doses for peripheral nerve blocks should not be exceeded 1, 2:

    • Bupivacaine: maximum 3.0 mg/kg with epinephrine, 1.3 mg/kg without epinephrine
    • Levobupivacaine: maximum 3.0 mg/kg with epinephrine, 2.0 mg/kg without epinephrine
    • Ropivacaine: maximum 3.0 mg/kg with epinephrine, 2.0 mg/kg without epinephrine

Important Considerations for Administration

  • Use ideal body weight for dose calculation rather than actual body weight, especially in obese patients 1, 2
  • Calculate the maximum allowable safe dosage (mg/kg) before administration to prevent local anesthetic systemic toxicity 2
  • Consider that smaller volumes with higher concentrations of local anesthetic may provide more effective and longer-lasting blocks than larger volumes with lower concentrations 3

Special Population Considerations

  • For pediatric patients, the European Society for Paediatric Anaesthesiology recommends the same volume (0.15 ml/kg) for landmark-based maxillary nerve block and external nasal nerve block 1
  • Reduce doses of amide local anesthetics by 30% in infants younger than 6 months 1, 2
  • Use lower doses in elderly patients and those with liver or cardiac impairment 2

Monitoring and Safety

  • Monitor for signs of local anesthetic systemic toxicity, including circumoral numbness, facial tingling, slurred speech, metallic taste, auditory changes, and hallucinations 1
  • Have lipid emulsion available for treatment of local anesthetic toxicity 1
  • Avoid using local anesthetics in very vascular areas without dose reduction due to increased systemic absorption 1, 2

Duration of Action

  • Expected duration of action for the recommended local anesthetics 1:
    • Bupivacaine: 180-600 minutes
    • Levobupivacaine: 180-600 minutes
    • Ropivacaine: 180-600 minutes

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Dose Calculation for Local Anesthetics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.